Abstract
Purpose of Review
Diabetic retinopathy remains the leading cause of blindness among working-age US adults even though timely screening and treatment prevent 90% of blindness. We summarize current knowledge and perspectives to better understand why diabetic eye screening rates remain low and future directions towards preventing blindness from diabetes.
Recent Findings
Significant advancements in the past 10 years include primary care and patient-oriented interventions as well as the use of teleophthalmology. In England, diabetic eye disease is no longer the leading cause of certifiable blindness following the implementation of a national teleophthalmology program for diabetic retinopathy.
Summary
Multiple workflow and systems-level barriers affect providers. Patient barriers include a limited understanding of screening and lack of access to care. Interventions have been developed, but new barriers exist towards sustaining their impact. More research is needed to identify and implement the best practices to increase diabetic eye screening rates long-term.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428–31. doi:10.4103/0301-4738.100542.
World Health Organization Western Pacific Region. Diabetic retinopathy. In: Blindness prevention and control. http://www.wpro.who.int/blindness prevention control/topics/diabetic retinopathy/en/. Accessed 4/15/17.
National Eye Institute. Facts about diabetic eye disease. https://nei.nih.gov/health/diabetic/retinopathy. Accessed 8/15/17.
•• Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017; doi:10.1007/s00592-017-0974-1. Summary of the national teleophthalmology program for diabetic eye screening in England
Holman GT, Beasley JW, Karsh BT, Stone JA, Smith PD, Wetterneck TB. The myth of standardized workflow in primary care. J Am Med Inform Assoc. 2016;23(1):29–37. doi:10.1093/jamia/ocv107.
Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209–14. doi:10.1370/afm.310.
Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635–41.
Holley CD, Lee PP. Primary care provider views of the current referral-to-eye-care process: focus group results. Invest Ophthalmol Vis Sci. 2010;51(4):1866–72. doi:10.1167/iovs.09-4512.
Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123(3):387–91. doi:10.1001/archopht.123.3.387.
• Hipwell AE, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O'Hare P, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening. BMJ Open. 2014;4(12):e005498. doi:10.1136/bmjopen-2014-005498. Semi-structured interviews were conducted to better understand patient perspectives in the English teleophthalmology program for diabetic eye screening. Knowledge of diabetic retinopathy and screening were patient facilitators, while work commitments, the use of dilating drops, and travel concerns were identified as barriers to patient participation
Willard-Grace R, Chen EH, Hessler D, DeVore D, Prado C, Bodenheimer T, et al. Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial. Ann Fam Med. 2015;13(2):130–8. doi:10.1370/afm.1768.
Reiss-Brennan B, Brunisholz KD, Dredge C, Briot P, Grazier K, Wilcox A, et al. Association of integrated team-based care with health care quality, utilization, and cost. JAMA. 2016;316(8):826–34. doi:10.1001/jama.2016.11232.
Maclennan PA, McGwin G Jr, Searcey K, Owsley C. A survey of Alabama eye care providers in 2010–2011. BMC Ophthalmol. 2014;14:44. doi:10.1186/1471-2415-14-44.
•• Silva PS, Aiello LP. Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes. JAMA Ophthalmol. 2015; doi:10.1001/jamaophthalmol.2015.0333. Overview of current challenges in teleophthalmology for diabetic eye screening
Kilmer G, Bynum L, Balamurugan A. Access to and use of eye care services in rural Arkansas. J Rural Health. 2010;26(1):30–5. doi:10.1111/j.1748-0361.2009.00262.x.
Conlin PR, Fisch BM, Cavallerano AA, Cavallerano JD, Bursell SE, Aiello LM. Nonmydriatic teleretinal imaging improves adherence to annual eye examinations in patients with diabetes. J Rehabil Res Dev. 2006;43(6):733–40.
Whited JD, Datta SK, Aiello LM, Aiello LP, Cavallerano JD, Conlin PR, et al. A modeled economic analysis of a digital tele-ophthalmology system as used by three federal health care agencies for detecting proliferative diabetic retinopathy. Telemed J E-Health. 2005;11(6):641–51. doi:10.1089/tmj.2005.11.641.
Ellish NJ, Royak-Schaler R, Passmore SR, Higginbotham EJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci. 2007;48(5):1989–94. doi:10.1167/iovs.06-0934.
• Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the compliance with annual diabetic eye exams survey. Ophthalmology. 2014;121(6):1212–9. doi:10.1016/j.ophtha.2013.12.016. A survey instrument was developed to assess predictors of adherence with diabetic eye screening. Factors associated with obtaining screening included insurance coverage, consideration of screening as a priority, the belief that eye disease could be detected, lower hemoglobin A1c levels, and longer duration of diabetes
• Zangalli CS, Murchison AP, Hale N, Hark LA, Pizzi LT, Dai Y, et al. An education- and telephone-based intervention to improve follow-up to vision care in patients with diabetes: a prospective, single-blinded, randomized trial. Am J Med Qual. 2016;31(2):156–61. doi:10.1177/1062860614552670. This prospective study evaluated the effectiveness of a multipronged intervention to improve adherence with diabetic eye exams. The intervention group had significantly increased rates of scheduling and obtaining diabetic eye exams
Thom DH, Ghorob A, Hessler D, De Vore D, Chen E, Bodenheimer TA. Impact of peer health coaching on glycemic control in low-income patients with diabetes: a randomized controlled trial. Ann Fam Med. 2013;11(2):137–44. doi:10.1370/afm.1443.
Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–53.
National Diabetes Statistics Report. Estimates of diabetes and its burden in the United States, 2014. In: prevention. CfDCa, editor. U.S. Department of Health and Human Services: Atlanta; 2014.
Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 1991;98(5):766–785. doi: 10.1016/S0161-6420(13)38011-7
Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States A. GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110(10):1952–9. doi:10.1016/S0161-6420(03)00817-0.
Hatef E, Vanderver BG, Fagan P, Albert M, Alexander M. Annual diabetic eye examinations in a managed care Medicaid population. Am J Manag Care. 2015;21(5):e297–302.
Munoz B, O'Leary M, Fonseca-Becker F, Rosario E, Burguess I, Aguilar M, et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol. 2008;126(7):968–74. doi:10.1001/archopht.126.7.968.
Maclennan PA, McGwin G Jr, Heckemeyer C, Lolley VR, Hullett S, Saaddine J, et al. Eye care use among a high-risk diabetic population seen in a public hospital's clinics. JAMA Ophthalmol. 2014;132(2):162–7. doi:10.1001/jamaophthalmol.2013.6046.
Owsley C, McGwin G Jr, Lee DJ, Lam BL, Friedman DS, Gower EW, et al. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2):174–81. doi:10.1001/jamaophthalmol.2014.4652.
10. Microvascular complications and foot care. Diabetes Care. 2017;40(Suppl 1):S88–s98. doi:10.2337/dc17-S013.
NCQA.org (2017). HEDIS Publications: Overview. [online] Available at: http://www.ncqa.org/HEDISQualityMeasurement/HED. [Accessed 2 Aug.2017].
NCQA.org. (2017). 2015 NCQA Health Plan Accreditation Requirements. [online] Available at: hhttp://www.ncqa.org/Portals/0/Programs/Accreditation/HPA/2015%20HPA%20SGs.pdf?ver=2017-01-21-153207-313. [Accessed 2 Aug. 2017].
Rein DB. Vision problems are a leading source of modifiable health expenditures. Invest Ophthalmol Vis Sci. 2013;54(14):Orsf18–22. doi:10.1167/iovs.13-12818.
Rowe S, MacLean CH, Shekelle PG. Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA. 2004;291(12):1487–95. doi:10.1001/jama.291.12.1487.
Wiggins MN, Landes RD, Bhaleeya SD, Uwaydat SH. Primary care physicians' knowledge of the ophthalmic effects of diabetes. Canad J Ophthalmol. 2013;48(4):265–8. doi:10.1016/j.jcjo.2013.03.011.
Delorme C, Boisjoly HM, Baillargeon L, Turcotte P, Bernard PM. Screening for diabetic retinopathy. Do family physicians know the Canadian guidelines? Can Fam Physician. 1998;44:1473–9.
Davidson JA. The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12 Suppl):S3–4. doi:10.4065/mcp.2010.0466.
American Academy of Ophthalmology Retina/Vitreous Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology. 2016. Available at: www.aao.org/ppp.
American Optometric Association Evidence-based Optometry Guideline Development Group. Eye Care of the Patient with Diabetes Mellitus. St. Louis, MO: American Optometric Association. 2014 Available at: https://www.aoa.org/Documents/EBO/EyeCareOfThePatientWithDiabetesMellitus%20CPG3.pdf
Dansky KH, Dirani R. The use of health care services by people with diabetes in rural areas. J Rural Health. 1998;14(2):129–37.
Sloan FA, Yashkin AP, Chen Y. Gaps in receipt of regular eye examinations among Medicare beneficiaries diagnosed with diabetes or chronic eye diseases. Ophthalmology. 2014;121(12):2452–60. doi:10.1016/j.ophtha.2014.07.020
Krishna S, Gillespie KN, McBride TM. Diabetes burden and access to preventive care in the rural United States. J Rural Health. 2010;26(1):3–11. doi:10.1111/j.1748-0361.2009.00259.x.
Lindenmeyer A, Sturt JA, Hipwell A, Stratton IM, Al-Athamneh N, Gadsby R, et al. Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract. 2014;64(625):e484–92. doi:10.3399/bjgp14X680965.
Odom JV. Vision, visual needs, and quality of life of older people in rural environments: a report and synthesis of a meeting. J Rural Health. 2001;17(4):360–3.
Halbert RJ, Leung KM, Nichol JM, Legorreta AP. Effect of multiple patient reminders in improving diabetic retinopathy screening: a randomized trial. Diabetes Care. 1999;22(5):752–5.
Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States’ health care: synthesis of micro-costing evidence. BMC Health Serv Res. 2014;14:556. doi:10.1186/s12913-014-0556-7.
Tozer K, Woodward MA, Newman-Casey PA. Telemedicine and diabetic retinopathy: review of published screening programs. J Endocrinol Diabetes. 2015;2(4) doi:10.15226/2374-6890/2/4/00131.
Cavallerano AA, Cavallerano JD, Katalinic P, Blake B, Rynne M, Conlin PR, et al. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center—the Joslin Vision Network eye health care model. Am J Ophthalmol. 2005;139(4):597–604. doi:10.1016/j.ajo.2004.10.064.
Garg S, Zimmer-Galler I. Telemedicine and remote imaging for diabetic retinopathy evaluation: an update. Retin Physician. 2013:49–51.
Mansberger SL, Sheppler C, Barker G, Gardiner SK, Demirel S, Wooten K, et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015;133(5):518–25. doi:10.1001/jamaophthalmol.2015.1
Murchison AP, Friedman DS, Gower EW, Haller JA, Lam BL, Lee DJ, et al. A multi-center diabetes eye screening study in community settings: study design and methodology. Ophthalmic Epidemiol. 2016;23(2):109–15. doi:10.3109/09286586.2015.1099682.
Silva PS, Cavallerano JD, Tolson AM, Rodriguez J, Rodriguez S, Ajlan R, et al. Real-time ultrawide field image evaluation of retinopathy in a diabetes telemedicine program. Diabetes Care. 2015;38(9):1643–9. doi:10.2337/dc15-0161.
Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, et al. Assessing the effect of personalized diabetes risk assessments during ophthalmologic visits on glycemic control: a randomized clinical trial. JAMA Ophthalmol. 2015;133(8):888–96. doi:10.1001/jamaophthalmol.2015.1312.
Frank RN. Can ophthalmologists achieve better blood glucose control in their diabetic patients? JAMA Ophthalmol. 2015;133(8):897–8. doi:10.1001/jamaophthalmol.2015.2258.
Vijan S, Fagerlin A. Diabetes risk assessment and glycemic control. JAMA. 2015;314(17):1861–2. doi:10.1001/jama.2015.11518.
Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish diabetic retinopathy screening programme. Diabetologia. 2013;56(8):1716–25. doi:10.1007/s00125-013-2928-7.
Taylor-Phillips S, Mistry H, Leslie R, Todkill D, Tsertsvadze A, Connock M, et al. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol. 2016;100(1):105–14. doi:10.1136/bjophthalmol-2014-305938.
DCCT/EDIC Research Group, Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, et al. Frequency of evidence-based screening for retinopathy in type 1 diabetes. N Engl J Med. 2017;376(16):1507–16. doi:10.1056/NEJMoa1612836.
Rein DB, Wittenborn JS, Zhang X, Allaire BA, Song MS, Klein R, et al. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res. 2011;46(5):1534–61. doi:10.1111/j.1475-6773.2011.01263.x.
Rosenberg JB, Tsui I. Screening for diabetic retinopathy. N Engl J Med. 2017;376(16):1587–8. doi:10.1056/NEJMe1701820.
Centers for Disease Control and Prevention. Self-management education: learn more. Feel better. https://www.cdc.gov/LearnMoreFeelBetter/. Accessed 8/15/17.
Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, et al. American Telemedicine Association Diabetic Retinopathy Telehealth Practice Recommendations Working Group. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17:814–837 . doi:10.1089/tmj.2011.0075.pmid:21970573.
Daskivich LP, Vasquez C, Martinez C Jr, Tseng CH, Mangione CM. Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services. JAMA Intern Med. 2017; doi:10.1001/jamainternmed.2017.0204.
Walton OB, Garoon RB, Weng CY, Gross J, Young AK, Camero KA, et al. Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol. 2016;134(2):204–9. doi:10.1001/jamaophthalmol.2015.5083.
Keenum Z, McGwin G Jr, Witherspoon CD, Haller JA, Clark ME, Owsley C. Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 2016;134(11):1221–8. doi:10.1001/jamaophthalmol.2016.3081.
Soliman AZ, Silva PS, Aiello LP, Sun JK. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012;27(5–6):221–7. doi:10.3109/08820538.2012.708812.
Goh JK, Cheung CY, Sim SS, Tan PC, Tan GS, Wong TY. Retinal imaging techniques for diabetic retinopathy screening. J Diabetes Sci Technol. 2016;10(2):282–94. doi:10.1177/1932296816629491.
Hansen MB, Abramoff MD, Folk JC, Mathenge W, Bastawrous A, Peto T. Results of automated retinal image analysis for detection of diabetic retinopathy from the Nakuru study, Kenya. PLoS One. 2015;10(10):e0139148. doi:10.1371/journal.pone.0139148.
Zhang W, Nicholas P, Schuman SG, Allingham MJ, Faridi A, Suthar T, et al. Screening for diabetic retinopathy using a portable, noncontact, nonmydriatic handheld retinal camera. J Diabetes Sci Technol. 2017;11(1):128–34. doi:10.1177/1932296816658902.
Rajalakshmi R, Arulmalar S, Usha M, Prathiba V, Kareemuddin KS, Anjana RM, et al. Validation of smartphone based retinal photography for diabetic retinopathy screening. PLoS One. 2015;10(9):e0138285. doi:10.1371/journal.pone.0138285.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Yao Liu and Rebecca Swearingen declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Funding
Yao Liu is supported by NIH/NEI K23 EY026518 and by an institutional grant from Research to Prevent Blindness, Inc.
Additional information
This article is part of the Topical Collection on Microvascular Complications—Retinopathy
Rights and permissions
About this article
Cite this article
Liu, Y., Swearingen, R. Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients. Curr Diab Rep 17, 94 (2017). https://doi.org/10.1007/s11892-017-0911-2
Published:
DOI: https://doi.org/10.1007/s11892-017-0911-2